Global Challenges with Oral Antivirals for COVID-19

Area of Science:

• Infectious Diseases
• Global Health
• Pharmacology

Background:

• Oral antivirals represent a critical advancement for managing COVID-19, particularly in resource-limited settings.
• Low- and middle-income countries (LMICs) face unique challenges in implementing these therapies.
• Potential barriers include drug interactions, adverse events, resistance, and equitable access.

Purpose of the Study:

• To highlight the transformative potential of oral antivirals in LMICs.
• To identify key challenges hindering the effective rollout and access to COVID-19 oral antivirals.
• To emphasize the importance of robust health system strengthening for future pandemic preparedness.

Main Methods:

• This analysis synthesizes current knowledge on oral antiviral use in LMICs.
• It examines potential challenges and proposes systemic improvements.
• The study draws on existing literature and expert insights.

Main Results:

• Oral antivirals can be pivotal in combating COVID-19 in LMICs.
• Significant challenges exist, including special populations, drug interactions, resistance, and access equity.
• Health system improvements are vital, regardless of specific drugs.

Conclusions:

• Equipping health systems in LMICs is paramount for successful oral antiviral deployment.
• Investments in manufacturing, community engagement, testing, and surveillance are essential.
• Strengthening healthcare infrastructure enhances resilience against current and future health crises.